International Society for Cell and Gene Therapy

To drive clinical translation of cell and gene therapies worldwide.
 

To improve lives through safe and effective cell and gene therapies. 
 

• Promote innovation in translational research
• Strive for excellence in everything we do
• Respect and support diversity and inclusivity
• Uphold the highest ethical standards
• Serve our members and advocate for our society
   

Established in 1992, the International Society for Cell & Gene Therapy (ISCT) is a global society of clinicians, regulators, researchers, technologists, and industry partners with a shared vision to translate cell and gene therapy into safe and effective therapies to improve patients' lives worldwide.

ISCT is the global leader focused on pre-clinical and translational aspects of developing cell and gene-based therapeutics, thereby advancing scientific research into innovative treatments for patients. ISCT offers a unique collaborative environment that addresses three key areas of translation: Academia, Regulatory, and Commercialization. Through strong relationships with global regulatory agencies, academic institutions, and industry partners, ISCT drives the advancement of research into a standard of care.

Comprising over 4,000 cell and gene therapy experts across five geographic regions and representation from over 60 countries, ISCT members are part of a global community of peers, thought leaders, and organizations invested in cell and gene therapy translation. For more information about the society, key initiatives, and upcoming meetings, please visit isctglobal.org, @ISCTglobal.